4 Small-Cap Biotechs to Consider if Gilead Isn???t Doing it For You
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"4 Small-Cap Biotechs to Consider if Gilead Isnt Doing it For You" ALT"4 Small-Cap Biotechs to Consider if Gilead Isnt Doing it For You"March 21, 2017By Mark Terry,…
22nd Century Group, Inc. Issues Annual Letter To Shareholders
Life Sciences Jobs ... Source: BioSpace
VistaPharm Cited for Contamination, Other Violations
FDA inspectors observed several violations at a VistaPharm facility in Largo, Fla., including contaminated water used in manufacturing and batches of drugs that were not tested for impurities. Source: Drug…
FDA Approved Over 99 Percent of Expanded Access Requests in 2016
The FDA granted over 99 percent of requests for expanded access in fiscal 2016, including 100 percent of emergency IND applications and protocols. Source: Drug Industry Daily
FDA Grants Regenerative Medicine Designation to Humacyte Vascular Tissue Therapy
The FDA granted expedited review to Humacyte’s tissue therapy under the new Regenerative Medicine Advanced Therapy pathway — one of the first products to receive the designation established by the…
VolitionRX Announces The Formation Of
Life Sciences Jobs ... Source: BioSpace
For Sale: Nektar Therapeutics Plans to License Hot New Opioid Drug
<IMG SRC"http://enewsletters.biospace.com/images/news/top-news-815x384-nektar.jpg" NAME"For Sale: Nektar Therapeutics Plans to License Hot New Opioid Drug" ALT"For Sale: Nektar Therapeutics Plans to License Hot New Opioid Drug"March 20, 2017By Mark Terry, BioSpace.com Breaking…
Creative BioMart Launched A Series Of Activities And Promotions Recently
Life Sciences Jobs ... Source: BioSpace
- Go to the previous page
- 1
- …
- 508
- 509
- 510
- 511
- 512
- 513
- 514
- …
- 610
- Go to the next page